Infertility and Ovarian Aging: Understanding Early Menopause and POI

When Infertility Raises Questions About Ovarian Aging

For women, fertility naturally declines as the ovaries age and egg quality changes over time. But that process doesn’t happen on the same timeline for everyone. For some women, ovarian aging begins earlier than expected, and one of the first signs can be having a hard time conceiving.

To understand why, it helps to understand what, exactly, is changing.

Basically, women are born with a finite number of ovarian follicles, the structures that house immature eggs and play a key role in estrogen production. Over time, that supply gradually declines. And as the ovaries age, they become less responsive to hormonal signals from the brain, making hormone production less predictable.

That shift can affect ovulation first. So, during perimenopause, ovulation often gets less consistent, and some cycles may not involve ovulation at all. Progesterone levels also fall, which messes with the usual balance between estrogen and progesterone that regulates the menstrual cycle.

This is a big part of why cycles can become more irregular during midlife, but the effects don’t stop there. Because estrogen influences many systems throughout the body, changing hormone patterns can also affect sleep, mood, metabolism, and much more.

And for some women, infertility can be one of the earliest outward signs that ovarian aging is happening faster than expected. Understanding the bigger hormonal picture can make fertility challenges easier to interpret and address.

Section 2: Perimenopause, Early Menopause, and Premature Ovarian Insufficiency: What’s the Difference?

These terms often get used interchangeably, but they actually describe totally different stages and conditions. Clarifying the difference can help make sense of both fertility challenges and hormone-related symptoms, so let’s break them down: 

• Perimenopause is the transition leading up to menopause, when estrogen and progesterone start fluctuating more unpredictably. Periods may become irregular, and symptoms like hot flashes or sleep changes can begin. That said, ovulation—and pregnancy—are still on the table. This phase often lasts several years (between 4 and 7), with the average age of menopause being around 51.

• Primaryremature Ovarian Insufficiency (POI) happens when ovarian function declines before age 40. It can cause irregular periods, infertility, and symptoms that look like perimenopause, but it’s considered a separate diagnosis because ovarian activity may still come and go unpredictably.  It also requires a thorough workup because an identifiable cause can be determined in 30-60% of cases..

• Early menopause is when menopause—marked by going 12 consecutive months without a period—happens before age 45.

• Premature menopause refers to menopause before age 40. In both cases, estrogen levels stay lower for longer, which may increase long-term risks like osteoporosis, heart disease, and possibly cognitive decline.

• Surgical menopause happens when both ovaries are removed. Unlike natural menopause, where hormones decline gradually, surgical menopause causes an abrupt drop in estrogen, which can make symptoms feel more sudden and intense.

One of the main reasons these distinctions matter is that timing changes risk. The earlier estrogen drops, the longer the body goes without some of its protective effects—which is why earlier treatment and long-term monitoring can be especially important.

Section 3: Cycle Changes and Symptoms That May Point to Early Ovarian Changes

Changes in your cycle are often one of the earliest signs that ovarian hormone patterns are shifting. And that doesn’t automatically mean something is wrong. In many cases, these changes are simply part of the normal transition toward menopause. 

Still, when they happen alongside fertility challenges or new hormone-related symptoms, they can offer useful clues about what’s going on.

Common patterns can include:

• Cycles getting shorter or longer than usual

• Skipped periods or months without ovulation

• Heavier or lighter bleeding than you’re used to

• Spotting between periods

• More unpredictable timing overall

When these changes are driven by inconsistent hormone production (translation: estrogen is climbing and dipping erratically, and progesterone is declining), you might notice changes beyond those affecting your period. Signs of ovarian changes can also show up as:

• Sleep problems

• Mood changes or increased irritability

• Vaginal dryness

• Brain fog or difficulty concentrating

• Hot flashes or night sweats

It’s also worth noting that the above symptoms can crop up even while your periods continue. And, for some women, they happen alongside fertility challenges—like taking longer to conceive or noticing ovulation feels less predictable than it used to.

Tracking both your cycle and your symptoms can help connect the dots. Specifically, it can help a clinician decipher whether you’re experiencing something related to reproductive aging or a separate fertility issue alone.

Section 4: What Tests Can Evaluate Early Menopause or POI?

If you and your care team think you might be experiencing early menopause or primary ovarian insufficiency (POI), there are a few different ways to figure out what’s going on. In most cases, it starts with bloodwork.

Some of the most commonly used hormone tests include:

• Follicle-stimulating hormone (FSH): FSH is a hormone made by the brain that signals the ovaries to mature eggs and produce estrogen. When the ovaries become less responsive, FSH levels often rise as the body tries to compensate. Persistently elevated FSH can be one clue that ovarian function is declining.

• Estradiol: Estradiol is the main form of estrogen made by the ovaries during reproductive years. Lower levels can suggest reduced ovarian activity, though estradiol can fluctuate significantly from day to day (especially during perimenopause).

• Anti-Müllerian hormone (AMH): AMH gives an estimate of ovarian reserve, meaning the number of remaining follicles in the ovaries. While it can offer insight into reproductive aging, it can’t predict exactly when menopause will happen.

But this hormone variability is one reason diagnosing early menopause or POI isn’t based on one test or bloodwork alone. Hormone levels can shift dramatically and rapidly,  so doctors often look at the bigger picture: your symptoms, cycle history, age, and overall reproductive health alongside lab results.

In some cases, more testing is done to rule out other causes or to evaluate related fertility concerns. That might include:

• Pelvic ultrasound: To assess the ovaries, uterus, and follicle count

• Hysterosalpingogram (HSG): An imaging test that checks whether the fallopian tubes are open

• Sonohysterogram: A saline ultrasound used to look more closely at the uterine lining

• Hysteroscopy or laparoscopy: Procedures that evaluate structural issues like fibroids, endometriosis, or scarring

And while these are all options, not everyone will need these tests to find out what’s going on. The right workup depends on your symptoms, age, and whether fertility is part of the conversation.

Section 5: Why the Timing of Menopause Matters for Long-Term Health

Menopause is often framed as the end of the reproductive years, but it affects far more than fertility. This is because estrogen plays a role in many systems across the body. 

To name a few, it helps:

• Maintain bone density

• Support blood vessel function

• Influence cholesterol metabolism

• Interact with brain pathways involved in memory, temperature, mood, and cognition

So when ovarian hormone production declines earlier than expected, those systems can feel the effects sooner, too.

To put it simply: Women who enter menopause early—whether naturally or through primary ovarian insufficiency (POI)—spend more of their lives with lower estrogen exposure. Over time, that longer hormonal gap can impact long-term health. 

One of the clearest examples is bone health. Estrogen helps regulate bone remodeling, the process of breaking down old bone and building new bone. Without enough of it, bone loss accelerates, increasing the risk of osteopenia, osteoporosis, and fractures earlier in life.

Cardiovascular health is another big one. Estrogen has protective effects on blood vessels and lipid balance, so earlier ovarian decline may contribute to a higher lifetime risk of heart disease. 

Research also suggests the brain may be part of this picture, too. Emerging data links earlier menopause—particularly in women with a history of primary infertility—to a greater risk of neurocognitive decline later in life. While researchers are still unpacking exactly why, it reinforces how interconnected reproductive and brain health really are.

None of this means early menopause guarantees these outcomes. But it does mean earlier awareness matters. Recognizing the transition sooner can open the door to proactive monitoring, lifestyle changes, and treatment options like hormone replacement therapy (HRT) that help protect long-term health before problems become harder to reverse.

Section 6: Treatment and Support Options for Early Menopause

Treatment for POI and early menopause is highly individualized, but in many cases, hormone replacement therapy (HRT) is one of the first options considered. That’s because when ovarian hormone production declines earlier than expected, replacing some of that lost estrogen can help bridge an important gap for both symptom relief and long-term health protection.

HRT works by replacing estrogen to stabilize hormone levels. If you still have a uterus, progesterone is usually added alongside it to help protect the uterine lining. Treatment can come in several forms, including pills, patches, gels, sprays, and creams, giving women more choices and a personalized approach. 

Estradiol Patch

Starting at $74.99 for 30 days of treatment

For many women, HRT is the most effective treatment for symptoms like hot flashes, sleep disruption, mood changes, and vaginal dryness. It can also slow the accelerated bone loss that often follows early menopause, helping lower the risk of osteoporosis and fractures over time.

Some research suggests hormone therapy started near the time of menopause may also support heart health and cognitive function in certain women.

All this to say, early menopause isn’t something you have to “just deal with.” There are treatment options, and the earlier you understand what’s happening, the more choices you have. And you don’t have to navigate it all alone. A provider who specializes in menopause can help weigh the potential benefits and risks to determine the safest and most effective approach for you.

Section 7: When to Talk With a Doctor About Fertility and Lifelong Screening

In general, women under 35 are advised to look into getting a fertility evaluation after they’ve been trying to conceive for one year without success. For women 35 and older, that window shortens to six months. This is because fertility and ovarian reserve tend to decline more quickly with age.

These are just the standard guidelines, though, and you don’t have to wait that long. For example, skipping cycles, having irregular periods, hot flashes, vaginal dryness, or other menopause-like symptoms can all be reasons to check in sooner—especially if they’re happening alongside fertility challenges. Those patterns can sometimes point to earlier ovarian changes that deserve a closer look.

The conversation shouldn’t stop once fertility is no longer the focus, either. A history of primary unexplained infertility or endometriosis may carry implications for long-term health, particularly if it overlaps with earlier menopause or primary ovarian insufficiency (POI).

That’s why more and more experts are calling for a clearer handoff between reproductive endocrinologists and midlife women’s health providers: So higher-risk patients don’t fall through the cracks once fertility treatment ends.

That handoff can shape what comes next, from earlier bone-density monitoring to more proactive cardiovascular screening. Connecting the dots early can protect your health long after your reproductive years.

“ For some women, infertility is the first clue that the menopause transition has begun.  Early recognition allows us to move beyond simply explaining why it’s happening - we can provide treatments that improve quality of life today while reducing health risks for years to come.” - Dr. Hayes

Frequently Asked Questions

What is the difference between Primary Ovarian Insufficiency (POI) and early menopause?

Primary Ovarian Insufficiency (POI) occurs when ovarian function declines before the age of 40, causing irregular periods and fertility challenges, though ovarian activity may still come and go unpredictably. Early menopause is specifically diagnosed when a woman goes 12 consecutive months without a period before the age of 45. While both involve a drop in estrogen, POI allows for intermittent ovarian function, whereas early menopause marks the permanent end of the menstrual cycle.

Which hormone tests evaluate early ovarian changes, and why is a diagnosis not based on bloodwork alone?

Clinicians commonly use blood tests to measure Follicle-stimulating hormone (FSH), Estradiol, and Anti-Müllerian hormone (AMH) to assess ovarian activity and egg reserve. However, a diagnosis cannot be based on bloodwork alone because hormone levels can fluctuate dramatically and rapidly from day to day, particularly during perimenopause. Instead, providers look at the entire clinical picture, combining lab results with an evaluation of your symptoms, age, and cycle history.

Why does the timing of early menopause or POI significantly impact long-term health?

Estrogen provides essential protective benefits throughout the body, including maintaining bone density, supporting blood vessel function, and regulating cholesterol metabolism. When ovarian function declines earlier than expected, women spend a longer portion of their lives with low estrogen exposure. This extended hormonal gap accelerates bone loss—increasing the risk of osteopenia and osteoporosis—and elevates the lifetime risk of cardiovascular disease and neurocognitive decline.

SOURCES 

1. Adebisi OM, et al. (2026). Female infertility. https://www.ncbi.nlm.nih.gov/books/NBK556033/

2. Anognostis PA, et al (2019). Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis. https://pubmed.ncbi.nlm.nih.gov/30400047/ 

3. Bove RI, et al. (2014). Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. https://pmc.ncbi.nlm.nih.gov/articles/PMC3902759/

4. Broekmans FJ, et al. (2009). Ovarian aging: mechanisms and clinical consequences. https://pubmed.ncbi.nlm.nih.gov/19589949/ 

5. Carlson KA et al. (2026). Menopause. https://www.ncbi.nlm.nih.gov/books/NBK507826/ 

6. Cavalcante MA, et al. (2023). Ovarian aging in humans: potential strategies for extending reproductive lifespan. https://pubmed.ncbi.nlm.nih.gov/36913129/ 

7. Cheng CH, et al. (2022). Osteoporosis due to hormone imbalance: An overview of the effects of estrogen deficiency and glucocorticoid overuse on bone turnover. https://pmc.ncbi.nlm.nih.gov/articles/PMC8836058/

8. Faubion ST, et al. (2016). Long-term health consequences of premature or early menopause and considerations for management. https://pmc.ncbi.nlm.nih.gov/articles/PMC4581591/ 

9. Gosset AN, et al. (2021). Menopausal hormone therapy for the management of osteoporosis. https://www.sciencedirect.com/science/article/abs/pii/S1521690X21000683

10. Gracia CL, et al. (2018). Onset of the menopause transition: The earliest signs and symptoms. https://pubmed.ncbi.nlm.nih.gov/30401544/

11. Hamada HA, et al. (2024). Premature ovarian insufficiency, early menopause, and induced menopause. https://pubmed.ncbi.nlm.nih.gov/37802711/ 

12. Mehta JA, et al. (2024). The menopausal transition period and cardiovascular risk. https://pubmed.ncbi.nlm.nih.gov/37752349/

13. Moolhuijsen LO, et al. (2020). Anti-Müllerian hormone and ovarian reserve: Update on assessing ovarian function. https://pmc.ncbi.nlm.nih.gov/articles/PMC7486884/

14. Orlowski MI, et al. (2023). Physiology, follicle stimulating hormone. https://www.ncbi.nlm.nih.gov/books/NBK535442/

15. Rodriguez MA, et al. (2025). Long‐term hormone therapy for perimenopausal and postmenopausal women. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004143.pub6/full

16. Sullivan SH, et al. (2016). Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause. https://pubmed.ncbi.nlm.nih.gov/27912889/ 

17. Szeliga AN, et al. (2021). Autoimmune diseases in patients with premature ovarian insufficiency-our current state of knowledge. https://pubmed.ncbi.nlm.nih.gov/33807517/ 

18. Tcherniakovsky MA, et al. (2026). Treatment of ovarian endometriosis: Number 1 – 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC12975110/

19. The North American Menopause Society. (2022). The 2022 hormone therapy position statement of The North American Menopause Society. https://pubmed.ncbi.nlm.nih.gov/35797481/ 

20. The Menopause Society. (2026). Infertility may lead to earlier menopause. https://menopause.org/press-releases/infertility-may-lead-to-earlier-menopause

21. Yang JA, et al. (2025). Estrogen deficiency in the menopause and the role of hormone therapy: integrating the findings of basic science research with clinical trials. https://pmc.ncbi.nlm.nih.gov/articles/PMC12072814/ 

22. Yong EU, et al. (2021). Menopausal osteoporosis: screening, prevention and treatment. https://pubmed.ncbi.nlm.nih.gov/33948669/